Non-small Cell Lung Cancer Stage II

A Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Pembrolizumab (SB27, EU Sourced Keytruda, and US Sourced Keytruda) in Subjects With Stage II-IIIA NSCLC Following Complete Resection and Adjuvant Platinum-based Chemotherapy

Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC

Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer

Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy

A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)

SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects

Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients

Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resectable NSCLC

Study to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients With Brain Metastases

Volatolomic and Proteomic Profile for Early Diagnosis of Lung Cancer

Combining ICI With SBRT or HypoFrx-RT for ES NSCLC

Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer Patients

The Canada Lymph Node Score Project: A Crossover Trial

Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer (EAST ENERGY)

Dose-painting Radiation for LA-NSCLC

Dynamic PET/CT Evaluated the Response of Neoadjuvant Anti-PD1 Combination With Chemotherapy for Ⅱa-Ⅲb NSCLC

LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC

Oncoxin® and Quality of Life in Cancer Patients